Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 182.76M
March 31, 2026 230.43M
December 31, 2025 276.28M
September 30, 2025 282.33M
June 30, 2025 289.69M
March 31, 2025 265.51M
December 31, 2024 267.35M
September 30, 2024 283.06M
June 30, 2024 324.82M
March 31, 2024 437.39M
December 31, 2023 248.19M
September 30, 2023 275.61M
June 30, 2023 280.75M
March 31, 2023 323.34M
Date Value
December 31, 2022 352.14M
September 30, 2022 392.36M
June 30, 2022 412.95M
March 31, 2022 216.96M
December 31, 2021 238.09M
September 30, 2021 257.70M
June 30, 2021 279.80M
March 31, 2021 299.26M
December 31, 2020 314.91M
September 30, 2020 329.76M
June 30, 2020 21.65M
March 31, 2020 25.70M
December 31, 2019 36.99M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Theriva Biologics, Inc. 11.34M
Unicycive Therapeutics, Inc. 61.42M
OnKure Therapeutics, Inc. 176.39M
ACADIA Pharmaceuticals, Inc. 956.47M